Medicare Enrolled
Dr. Ivor Percent, M.D.
Hematology · Port Charlotte, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Percent from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Percent? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Percent
Dr. Ivor Percent is a hematology in Port Charlotte, FL, with 19 years in practice. Based on federal Medicare data, Dr. Percent performed 320,884 Medicare services across 7,063 unique beneficiaries.
Between the years covered by Open Payments, Dr. Percent received a total of $25,254 from 97 pharmaceutical and/or device companies across 874 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Percent is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 7% volume in FL$ $25,254 industry payments
Medicare Practice Summary
Medicare Utilization ↗320,884
Medicare services
Top 7% in FL for hematology
7,063
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16,889 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 74,970 | $0 | $4 |
| Iron sucrose injection (Venofer) | 28,200 | $0 | $5 |
| Iron infusion (Injectafer) | 22,500 | $1 | $3 |
| Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 21,660 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 15,800 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 14,794 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 14,690 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 13,860 | $0 | $2 |
| Oxaliplatin chemotherapy injection | 12,500 | $0 | $12 |
| Paclitaxel chemotherapy injection | 11,346 | $0 | $2 |
| Nivolumab injection (Opdivo) | 11,320 | $24 | $72 |
| Daratumumab injection (Darzalex) | 10,440 | $38 | $110 |
| Denosumab injection (Prolia/Xgeva) | 9,300 | $18 | $51 |
| Injection, mepolizumab, 1 mg | 9,100 | $23 | $72 |
| Azacitidine chemotherapy injection | 7,000 | $0 | $4 |
| Immune globulin infusion (Gammagard) | 5,806 | $36 | $108 |
| Omalizumab injection (Xolair) for asthma/allergy | 5,190 | $30 | $95 |
| Injection, durvalumab, 10 mg | 5,002 | $62 | $191 |
| Dexamethasone injection (steroid) | 3,568 | $0 | $3 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,168 | $26 | $116 |
| Blood draw (venipuncture) | 3,125 | $8 | $9 |
| Complete blood count (CBC) with differential | 3,086 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,780 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,340 | $10 | $69 |
| Office visit, established patient (30-39 min) | 1,305 | $95 | $339 |
| Injection of additional new drug or substance into vein | 1,085 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 952 | $0 | $9 |
| Office visit, established patient (20-29 min) | 759 | $63 | $239 |
| Infliximab infusion (Remicade) | 650 | $27 | $124 |
| Administration of chemotherapy into vein, 1 hour or less | 596 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 578 | $47 | $189 |
| Injection, leucovorin calcium, per 50 mg | 527 | $3 | $12 |
| Injection, carboplatin, 50 mg | 452 | $2 | $41 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 420 | $1 | $6 |
| Injection, fluorouracil, 500 mg | 406 | $2 | $7 |
| Injection, diphenhydramine hcl, up to 50 mg | 307 | $1 | $3 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 298 | $17 | $59 |
| Red blood count, automated test | 293 | $4 | $10 |
| Injection, magnesium sulfate, per 500 mg | 278 | $1 | $2 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 226 | $3 | $11 |
| Administration of chemotherapy into vein, each additional hour | 211 | $21 | $79 |
| Infusion into a vein for hydration, each additional hour | 187 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 186 | $15 | $56 |
| Infusion, normal saline solution , 1000 cc | 169 | $2 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 164 | $54 | $206 |
| Administration of additional new drug or substance into vein, 1 hour or less | 154 | $49 | $178 |
| New patient office visit (45-59 min) | 121 | $124 | $453 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 117 | $21 | $84 |
| Injection of drug or substance into vein | 117 | $28 | $156 |
| Infusion into a vein for hydration, 31-60 minutes | 81 | $23 | $156 |
| Automated urinalysis | 72 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 72 | $139 | $474 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $135 | $562 |
| Administration of additional new drug or substance into vein using push technique | 66 | $42 | $170 |
| Prothrombin time test (blood clotting) | 59 | $4 | $15 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $25 | $89 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 44 | $120 | $637 |
| Red blood count automated, with additional calculations | 43 | $5 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 42 | $15 | $56 |
| Drawing of blood for a medical problem | 36 | $65 | $277 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 30 | $1 | $7 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 28 | $4 | $15 |
| Hospital follow-up visit, moderate complexity | 25 | $63 | $197 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 24 | $126 | $467 |
| Initial hospital admission, moderate complexity | 22 | $92 | $377 |
| Initial hospital admission, high complexity | 13 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.8% high complexity
64.2% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,254
Total received (2018-2024)
Avg $3,608/year across 7 years
Top 18% in FL for hematology
97
Companies
874
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,149 (60.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,106 (40.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,420
2023$3,033
2022$3,047
2021$9,139
2020$1,795
2019$2,812
2018$2,008
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim International GmbH
$8,149
Novartis Pharmaceuticals Corporation
$1,263
F. Hoffmann-La Roche AG
$1,185
E.R. Squibb & Sons, L.L.C.
$1,181
PFIZER INC.
$678
Janssen Biotech, Inc.
$665
Merck Sharp & Dohme LLC
$662
Genentech USA, Inc.
$602
Lilly USA, LLC
$596
Incyte Corporation
$525
Gilead Sciences, Inc.
$519
Merck Sharp & Dohme Corporation
$499
GENZYME CORPORATION
$498
Celgene Corporation
$487
Daiichi Sankyo Inc.
$462
Astellas Pharma US Inc
$446
Seagen Inc.
$383
Exelixis Inc.
$371
BeiGene USA, Inc.
$318
AstraZeneca Pharmaceuticals LP
$302
Amgen Inc.
$293
GlaxoSmithKline, LLC.
$278
Boehringer Ingelheim Pharma GmbH & Co.KG
$258
Regeneron Healthcare Solutions, Inc.
$255
Bayer HealthCare Pharmaceuticals Inc.
$198
ARRAY BIOPHARMA INC
$189
ABBVIE INC.
$158
Takeda Pharmaceuticals U.S.A., Inc.
$146
Ethicon Inc.
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
Puma Biotechnology, Inc.
$131
JAZZ PHARMACEUTICALS INC.
$130
Deciphera Pharmaceuticals Inc.
$124
Mirati Therapeutics, Inc.
$111
Kite Pharma, Inc.
$105
Rigel Pharmaceuticals, Inc.
$100
Karyopharm Therapeutics Inc.
$100
Intuitive Surgical, Inc.
$96
Eisai Inc.
$94
AbbVie Inc.
$92
Seattle Genetics, Inc.
$90
PharmaEssentia USA Corporation
$89
Dendreon Pharmaceuticals LLC
$84
SERVIER PHARMACEUTICALS LLC
$84
EMD Serono, Inc.
$82
Stemline Therapeutics Inc.
$79
Pharmacyclics LLC, An AbbVie Company
$78
EISAI INC.
$76
Bayer Healthcare Pharmaceuticals Inc.
$76
SANOFI-AVENTIS U.S. LLC
$76
Myovant Sciences Inc.
$73
TerSera Therapeutics LLC
$70
ADC Therapeutics America, Inc.
$70
Taiho Oncology, Inc.
$69
Blueprint Medicines Corporation
$66
Pharmacosmos Therapeutics Inc.
$63
Dova Pharmaceuticals
$61
Alnylam Pharmaceuticals Inc.
$60
SOBI, INC
$59
PUMA BIOTECHNOLOGY, INC.
$50
Pharmacyclics LLC, an AbbVie Company
$50
AMAG Pharmaceuticals, Inc.
$49
Foundation Medicine, Inc.
$43
Acrotech Biopharma Inc.
$41
Kyowa Kirin, Inc.
$38
Sobi, Inc
$35
Sumitomo Pharma America, Inc.
$32
Alexion Pharmaceuticals, Inc.
$32
G1 Therapeutics, Inc.
$31
CTI BioPharma Corp.
$30
Sirtex Medical Inc
$26
SpringWorks Therapeutics, Inc.
$26
Telix Pharmaceuticals
$25
NanoString Technologies, Inc.
$24
Adaptive Biotechnologies Corporation
$24
Iovance Biotherapeutics, Inc.
$24
Sun Pharmaceutical Industries Inc.
$24
GE HealthCare
$22
AbbVie, Inc.
$22
Secura Bio, Inc.
$21
MorphoSys, US Inc.
$20
Cumberland Pharmaceuticals, Inc.
$19
Epizyme, Inc.
$18
Genmab U.S., Inc.
$17
Immunomedics, Inc.
$16
Aveo Pharmaceuticals, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$16
Epizyme, Inc.,
$16
Helsinn Therapeutics (U.S.), Inc.
$16
Sysmex Inostics Inc
$15
Agios Pharmaceuticals, Inc.
$15
Clovis Oncology, Inc.
$15
Acrotech Biopharma LLC
$14
Horizon Therapeutics plc
$13
Teva Pharmaceuticals USA, Inc.
$12
Heron Therapeutics, Inc.
$12
Veracyte, Inc.
$1
Top 3 companies account for 42.0% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xolair · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
10
Per 100K population
5.1
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Percent is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (low-engagement, top 18%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Percent experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Percent performed 74,970 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Percent receive payments from pharmaceutical companies?
Yes. Dr. Percent received a total of $25,254 from 97 companies across 874 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Percent's costs compare to other hematologys in Port Charlotte?
Dr. Percent's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Percent) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Port Charlotte
Browse hematologys in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Boehringer Ingelheim International GmbH Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim International GmbH.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology